You are here: Industry Insights > Pfizer

News List

Over a quarter of UK adults have received both COVID-19 vaccine doses pharmatimes
April 28, 2021
The Department of Health and Social Care (DHSC) has announced that over a quarter of adults in the UK have now received both doses of a COVID-19 vaccine in the latest vaccination milestone.
Israel assesses myocarditis cases linked to Pfizer-BioNTech Covid-19 vaccine pharmaceutical-technology
April 27, 2021
The Israel Health Ministry is examining a small number of cases related to inflammation of the heart muscle called ‘myocarditis’ in individuals inoculated with Pfizer and BioNtech’s Covid-19 vaccine.
Start of Production in Record Time: Evonik Delivers First Lipids from German Facility to BioNTech americanpharmaceuticalreview
April 23, 2021
Evonik is helping to accelerate the production of the COVID-19 vaccine from Pfizer-BioNTech by suppling an essential component. Evonik is delivering first batches of the urgently needed lipids for the mRNA-based vaccine to BioNTech months earlier than ...
In discussions with India for vaccine supply: Pfizer expresspharma
April 23, 2021
A not-for-profit price offered for its vaccine for the government's immunisation programme, informs company.
New advice on COVID-19 vaccination for pregnant women in UK pharmatimes
April 20, 2021
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that pregnant women in the UK be offered COVID-19 vaccination at the same time as the rest of the population.
Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU contractpharma
April 20, 2021
EU orders 100 million additional doses of COMIRNATY, bringing total doses to 600 million for 27 EU member states.
Pfizer, Myovant begin dosing in relugolix contraceptive study pharmatimes
April 15, 2021
Pfizer and Myovant have announced that dosing has begun in a Phase III study evaluating the contraceptive efficacy of their relugolix combination tablet.
Pfizer/BioNTech’s vaccine to touch sales of $24.8 billion by 2021: GlobalData expresspharma
April 15, 2021
Pfizer/BioNTech’s Comirnaty (tozinameran) is forecast to have peak sales of $24.8bn by 2021, which is only its second year on the market. This is a 20 per cent increase over Humira’s peak sales of $20.5 billion, suggesting that Comirnaty could be the ...
COVAX has delivered vaccines to over 100 countries, despite supply hits: GAVI/WHO expresspharma
April 09, 2021
The COVAX vaccine facility has delivered nearly 38.4 million doses of COVID-19 vaccines to more than 100 countries and economies across six continents as of Thursday, six weeks after it began to roll out supplies, a statement said.
US commences research on allergic reaction risk in Moderna, Pfizer vaccines expresspharma
April 08, 2021
Several allergic reaction incidents, including serious episodes, known as anaphylaxis, have been reported in the US after vaccinations of Pfizer/BioNTech and Moderna shots.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page